The aim of the study is to determine how safe and effective PF-04965842 is when taken as the treatment for moderate to severe atopic dermatitis in patients aged 12 years or older.
- Registry ID
- EUCTR2018-001136-21
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Pfizer Inc., 235 East 42nd Street, New York, NY 10017
- Start date
- 2018-12-19
- Completion date
- 2019-08-13
- Last update
- 2026-08-16
Conditions
- Moderate to severe atopic dermatitis
Summary
To assess the efficacy of PF-04965842 compared with placebo in subjects aged 12 years and older with moderate to severe atopic dermatitis.
Locations
- , , Bulgarian Drug Agency
- , , Hungary
- , , Czechia
- , , UK
- , , Germany
- , , Poland
- , , Latvia
View on source registry